PURE Bioscience, Inc. (PURE)

Market Cap	10.02M
Revenue (ttm)	1.80M
Net Income (ttm)	-4.05M
Shares Out	111.36M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,875
Open	0.143
Previous Close	0.155
Day's Range	0.130 - 0.143
52-Week Range	0.070 - 0.240
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 13, 2023

About PURE

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control,...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• IPO Date: Aug 8, 1996
• Employees: 15
• Stock Exchange: OTCMKTS
• Ticker Symbol: PURE

Financial Performance

In 2022, PURE's revenue was $1.85 million, a decrease of -52.81% compared to the previous year's $3.93 million. Losses were -$3.49 million, 50.5% more than in 2021.